Anyone who has followed the Creso Pharma (CPH.ASX) story over the past year was aghast when they read the recent company announcement revealing that CPH issued Assena Wealth Solutions…
Craig Amos
XIV, a NASDAQ traded inverse volatility ETN, cratered in after-hours trading Monday and now appears worthless. This has financial pundits pondering the contagion effects to Credit Suisse, the issuer,…
So there I was minding my own business in a makeshift bar along Sukhumvit Road, observing the ladyboys fight the police when I was rudely interrupted by a Google…
Did we tell you, or did we tell you? No surprise as here at Equity Guru we have quite the track record at nailing market calls. As 2017 was…
A while back our principal Chris Parry issued a heads up stating money was on the move back into energy metals. He thought the message important enough to alert…
While the first snow recently dusted the streets of Vancouver, Sydneysiders have sweltered with temperatures soaring past 43 degrees Celcius (109°F) this past weekend. The financial glitterati are making…
Something quite remarkable took place at the 2002 Winter Olympics in Salt Lake City. Australian Steven Bradbury took out the gold medal in the men’s short track 1000m speed…
Thanks for being part of Equity Guru this year! We’ve experienced fantastic growth in 2017 and it was great to have you along for the ride. We hope our…
It’s the story that has it all: An exotic location, a missing (presumed dead) geologist, the vaporization of 6 billion in shareholder funds and a CEO who died in…
The Hydroponics Company (THC.ASX), which listed on 4th May, is the latest cannabis outfit to tap the market for funds, halting their stock through the week to undertake an…